The Advanced Bioeconomy: State of the Industry 2019

Trend #2, the targets themselves. We’re tracking today more than 60 molecules that are targeted in research as end products, and more than a dozen at commercial scale. Just one example, biobased BTX is heading for scale, and BDO is already there. Key is to look for drop-in markets where there is a cost prohibitive process in using petroleum.